#access2meds

Matthew Rimmerdrrimmer@aus.social
2025-05-20

World agrees pandemic accord for tackling outbreaks of disease

theguardian.com/global-develop

Hailed as ‘a victory for public health,’ the agreement aims to build on the lessons of Covid-19 and protect the globe from pathogenic threats.

#access2meds #pandemictreaty #health #covid19 #thenextpandemic #WHO

Matthew Rimmerdrrimmer@aus.social
2025-05-18

‘Pandemic potential’ on our doorstep
Australia is “surrounded” by the deadly H5N1 strain of bird flu. And it is morphing as sea animals and birds bring it ever closer to these shores. abc.net.au/news/2025-05-18/ant #flu #influenza #biodiversity #pandemic #access2meds #pandemictreaty

Matthew Rimmerdrrimmer@aus.social
2025-05-14

The World Health Organization has been thrown into crisis by Trump’s order directing the US to withdraw from the agency irishtimes.com/health/2025/05/ Dr Mike Ryan is dropped from WHO executive team amid ‘painful’ cost cuts. Dr Ryan has been managing health emergencies in WHO for the past 27 years, and most recently led WHO’s emergency response to the Covid-19 pandemic. #health #access2meds #WHO #pandemics

Matthew Rimmerdrrimmer@aus.social
2025-05-12

'The World Health Organization (WHO) and Medicines Patent Pool (MPP) have... announced a sublicensing agreement between MPP and a Nigerian health technology company – Codix Bio – to start development and manufacturing of rapid diagnostic tests (RDTs) using technology transferred from global in-vitro diagnostics company – SD Biosensor (SDB). This agreement will contribute to advancing equitable access to vital diagnostic tools through local production, expanding manufacturing capacity in the African Region.' who.int/news/item/09-05-2025-w #patent #patentpools #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-05-08

Matthew Rimmer, ‘The Summit of the Future: Intellectual Property and the Sustainable Development Goals’, The Summit of the Future, QUT Energy Transition Centre, 29 November 2024, youtu.be/ao9QTmd-8zE #SDGs #Summitofthefuture #OpenInnovation #IndigenousIP #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-04-22

Countries finalize historic pandemic agreement after three years of negotiations
news.un.org/en/story/2025/04/1
#pandemictreaty #WHO #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-04-09
Matthew Rimmerdrrimmer@aus.social
2025-04-09

Trump flags ‘major tariff on pharmaceuticals’ as trade chief says US ‘running up score’ on Australia theguardian.com/australia-news
US president says he will shortly announce the new tariff on pharmaceuticals but does not give any details. #trade #access2meds #tariffs

Matthew Rimmerdrrimmer@aus.social
2025-04-01

Albanese tells Trump that Australia is ‘not negotiating’ on biosecurity, medicines and news theguardian.com/australia-news
Office of US trade representative releases report on ‘foreign trade barriers’ including Australia’s biosecurity regime for imported beef, pork and poultry #trade #auslaw #auspol #uslaw #uspol #AUSFTA #access2meds #agriculture #media

Matthew Rimmerdrrimmer@aus.social
2025-03-31

The European Patent Office declared a patent owned by CureVac valid, after a challenge from drugmaker BioNTech, the company said uk.finance.yahoo.com/news/euro #patent #COVID19 #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-03-22

Big pharma is taking aim at Australia’s PBS. Could Trump force us to pay more for medicines? theguardian.com/australia-news #patent #access2meds #auspol #uspol #IP #health

Matthew Rimmerdrrimmer@aus.social
2025-03-20

'For a nation at the forefront of medical innovation and drug manufacture, vast numbers of Americans simply can't afford to access to vital medicines.' abc.net.au/news/2025-03-21/beh #patent #access2meds #auspol #uspol #IP #health

Matthew Rimmerdrrimmer@aus.social
2025-03-19

Australia defends Pharmaceutical Benefits Scheme as US companies urge Trump to impose reciprocal tariffs abc.net.au/news/2025-03-19/aus #IP #trade #health #PBS #tariffs #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-03-10

Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna fiercepharma.com/pharma/pfizer #patent #COVID19 #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-03-10

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent reuters.com/business/healthcar
'In a statement, the court in the city of Duesseldorf said that Pfizer and BioNTech would have to provide information on earnings derived from the use of the patent and that they owe Moderna appropriate compensation, though the ruling can still be appealed to a higher court.

The court added that Pfizer and BioNTech had argued they were authorised by a press release from Moderna to use the technology behind the patent until the World Health Organization declared in May 2023 that COVID-19 was no longer a global health emergency.'

#COVID19 #patent #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-03-10

Pfizer, BioNTech convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
reuters.com/legal/government/p
The cases are BioNTech SE v. ModernaTX Inc, Patent Trial and Appeal Board, Nos. IPR2023-01358 and IPR2023-01359. #patent #COVID19 #access2meds

Matthew Rimmerdrrimmer@aus.social
2025-03-02

'A bloodbath': HIV field is reeling after billions in U.S. funding are axed
science.org/content/article/bl
USAID's promises to support lifesaving efforts are broken, putting millions
in peril #access2meds #HIV #AIDS #UNAIDS

Client Info

Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst